Search results
In the Alabama Legislature, it’s culture wars first, retirees second | BRIAN LYMAN
The Montgomery Advertiser via Yahoo News· 5 days agoI could go on. The Legislature approved a bill forcing employers to prolong labor strife. They...
U.S. government’s multimillion-dollar poop-picking program is expanding, has international ambitions
The Washington Times· 4 days agoThe U.S. government is expanding its program to collect your poop and believes picking through the...
Article reported on rising cancer rates before pandemic, didn't link to vaccines | Fact check
USA Today· 6 days agoA May 23 Instagram post (direct link, archive link) shows a Daily Mail article with a color-coded...
Journal Urges It's Time To Regulate Troubled Teen Behavioral Programs
Digital Journal· 19 hours agoA recent paper published in The Journal of Legislation about the need for greater oversight of the "troubled teen" behavioral industry conveys how "there has never been a more opportune (and ...
4 ways vaccine skeptics mislead you on measles and more
Sun-Sentinel· 6 days agoMeasles is on the rise in the United States. In the first quarter of this year, the number of cases...
In the Alabama Legislature, it’s culture wars first, retirees second | BRIAN LYMAN
Montgomery Advertiser· 5 days agoAs lawmakers locked in $12 billion in spending late in the recently-concluded legislative session,...
4 ways vaccine skeptics mislead you on measles and more
The Columbian· 3 days agoMeasles is on the rise in the United States. In the first quarter of this year, the number of cases...
Journal Urges It's Time To Regulate Troubled Teen Behavioral Programs
Digital Journal· 20 hours agoA recent paper published in The Journal of Legislation about the need for greater oversight of the "troubled teen" behavioral industry conveys how "there has never been a more opportune (and ...
4 ways vaccine skeptics mislead you on measles and more
Tampa Bay Times· 7 days agoMeasles is on the rise in the United States. In the first quarter of this year, the number of cases...
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Morningstar· 3 days agoSummit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) announced that the Journal of the American Medical Association (JAMA) published a manuscript titled, “Ivonescimab Plus ...